PubMed:10814695 / 0-191 JSONTXT

{"project":"Glycan-Motif","denotations":[{"id":"T1","span":{"begin":86,"end":97},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T2","span":{"begin":141,"end":153},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"}],"text":"Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia.\nSialic acids typically present as terminal sugars "}

{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T1","span":{"begin":86,"end":97},"obj":"Glycan_Motif"},{"id":"T2","span":{"begin":141,"end":153},"obj":"Glycan_Motif"}],"attributes":[{"id":"A1","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY"},{"id":"A2","pred":"image","subj":"T2","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY"}],"text":"Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia.\nSialic acids typically present as terminal sugars "}

{"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":140},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":140},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":140},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia.\nSialic acids typically present as terminal sugars "}

{"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T1","span":{"begin":86,"end":97},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"},{"id":"T2","span":{"begin":141,"end":153},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"}],"text":"Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia.\nSialic acids typically present as terminal sugars "}

{"project":"GlycoBiology-FMA","denotations":[{"id":"_T1","span":{"begin":45,"end":55},"obj":"FMAID:167180"},{"id":"_T2","span":{"begin":111,"end":130},"obj":"FMAID:197293"},{"id":"_T3","span":{"begin":111,"end":130},"obj":"FMAID:83032"},{"id":"_T4","span":{"begin":117,"end":130},"obj":"FMAID:197290"},{"id":"_T5","span":{"begin":117,"end":130},"obj":"FMAID:83030"},{"id":"_T6","span":{"begin":117,"end":130},"obj":"FMAID:83031"},{"id":"_T7","span":{"begin":117,"end":130},"obj":"FMAID:197292"},{"id":"_T8","span":{"begin":184,"end":190},"obj":"FMAID:196724"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia.\nSialic acids typically present as terminal sugars "}

{"project":"GO-MF","denotations":[{"id":"T1","span":{"begin":45,"end":55},"obj":"http://purl.obolibrary.org/obo/GO_0003823"}],"text":"Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia.\nSialic acids typically present as terminal sugars "}

{"project":"EDAM-topics","denotations":[{"id":"T1","span":{"begin":175,"end":183},"obj":"http://edamontology.org/topic_0749"}],"text":"Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia.\nSialic acids typically present as terminal sugars "}

{"project":"GlyTouCan-IUPAC","denotations":[{"id":"GlycanIUPAC_T1","span":{"begin":184,"end":190},"obj":"\"http://rdf.glycoinfo.org/glycan/G59665TO\""},{"id":"GlycanIUPAC_T2","span":{"begin":184,"end":190},"obj":"\"http://rdf.glycoinfo.org/glycan/G32915EI\""},{"id":"GlycanIUPAC_T3","span":{"begin":184,"end":190},"obj":"\"http://rdf.glycoinfo.org/glycan/G60625TS\""}],"text":"Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia.\nSialic acids typically present as terminal sugars "}

{"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":101,"end":139},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0000870"}],"text":"Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia.\nSialic acids typically present as terminal sugars "}

{"project":"GlyCosmos15-HP","denotations":[{"id":"T1","span":{"begin":111,"end":139},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0006721"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia.\nSialic acids typically present as terminal sugars "}

{"project":"Glycosmos15-CL","denotations":[{"id":"T1","span":{"begin":117,"end":130},"obj":"Cell"}],"attributes":[{"id":"A1","pred":"cl_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL:0017005"}],"text":"Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia.\nSialic acids typically present as terminal sugars "}